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Transcriptional profiling
The transcriptome, the entire repertoire of transcripts in 
a  species,  represents  a  key  link  between  information 
encoded in DNA and phenotype. A fully quantitatively 
described transcriptome is dauntingly large. For example, 
there are more than 3 billion bases in the human genome, 
about 1014 cells in the body, each cell has about 300,000 
molecules of RNA [1], and the average gene size is about 
28 kilobase pairs [2]. Thus, for a full representation of a 
human, there are about 8.423 (280000 × 300000 × 1014) 
RNA  bases  in  the  full  transcriptome.  The  tools  for 
profiling RNA have been available for years, as Northern 
blots,  reverse-transcription  PCR  (RT-PCR),  expressed 
sequence  tags  (ESTs),  and  serial  analysis  of  gene 
expression (SAGE). But the rapid and high-throughput 
quantification of the transcriptome became a possibility 
only  with  the  development  of  gene  expression 
microarrays  [3].  With  the  more  recent  advent  of 
techniques  for  direct  sequencing  of  the  transcriptional 
output of the genome, we can now at least begin to think 
about a complete transcriptional characterization of all 
the cells of an organism.
Microarrays
Gene expression microarray results have produced much 
important information about how the transcriptome is 
deployed in different cell types [4] and tissues [5], how 
gene expression changes across development states [6,7] 
and disease phenotypes [8,9], and how it varies within 
[10]  and  between  species  [11].  They  have  also  led  to 
surprising and contentious conclusions on how much of 
the genome is transcribed into non-coding RNAs.
The  starting  point  for  a  microarray  is  a  set  of  short 
oligonucleotide  probes  representing  genomic  DNA.  A 
typical  modern  microarray  consists  of  patches  of  such 
probes complementary to the transcripts whose presence 
is  to  be  investigated,  and  immobilized  on  a  solid 
substrate.  In  modern  arrays,  probe  design  is  usually 
based  on  genome  sequence  or  on  known  or  predicted 
open  reading  frames  and  usually  multiple  probes  are 
designed per gene model. Transcripts are extracted from 
samples of the cell or tissues to be investigated, labeled 
with  fluorescent  dyes  (either  one  color  or  two), 
hybridized  to  the  arrays,  washed,  and  scanned  with  a 
laser.  Probes  that  correspond  to  transcribed  RNA 
hybridize  to  their  complementary  target.  Because 
transcripts  are  labeled  with  fluorescent  dyes,  light 
intensity can be used as a measure of gene expression.
Expression  profiling  by  microarrays  has  been  very 
successful. Searching the term ‘microarray’ in PubMed 
produces more than 40,000 citations. The Gene Expression 
Omnibus (GEO), the repository of transcript  ome datasets 
managed  by  the  National  Center  for  Biotechnology 
Information,  has  more  than  520,000  individual  experi-
ments archived and around 21,000 project submissions, 
most produced from microarrays. This impressive body 
of work has produced a range of mature strategies for 
data analysis and experimental design [12].
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and  kinetics  of  array  assays,  the  quality  of  microarray 
data  has  improved  dramatically.  In  the  early  days, 
microarrays designed by different companies appeared to 
produce different results with the same samples [13]. The 
fluorescent  readout  of  hybridization  intensities  varied 
between different laser scanners and there was variation 
in  reproducibility  between  different  labs  [14].  Ozone 
differentially  degraded  the  fluorescent  dyes  [15]. 
Recognition  of  biases  and  other  artifacts  by  individual 
labs and organizations, such as the MicroArray Quality 
Control (MAQC) consortium, has led to the development 
of quality control standards that operate to ensure the 
utility of a well performed microarray experiment [16]. 
For example, experimental and computational methods 
have been developed for dealing with systematic variation 
between laboratories [12,17-19]. As with any measure-
ment tool, it is important to know the biases inherent in 
the technique. For microarrays, it has taken a decade to 
understand these biases but for microarrays this has now 
been achieved and stable analytical solutions have been 
developed.
Deep sequencing
Meanwhile, a revolution in the analysis of RNA has come 
about  through  the  development  of  tools  for  massively 
parallel sequencing of DNA molecules. Not very many 
years  ago  a  graduate  student  using  a  slab  gel 
electrophoresis  instrument  with  fluorescent  terminator 
chemistry would be excited to get 500-800 base pairs of 
high quality sequence data from a single gene after about 
a  week’s  worth  of  work.  For  perspective,  Drosophila 
melanogaster  has  120  million  bases  in  its  small  and 
compact genome and so a hard-working graduate student 
would  need  more  than  400  years  to  complete  one 
genome. In early genome projects, even with an entire 
team  of  people  spread  across  both  academic  and 
commercial  sectors  of  science  it  took  several  years  of 
work  to  complete  the  D.  melanogaster  genome  [20]. 
Today, roughly 10 years later, we have instruments that 
can  sequence  multiple  fly  genomes  in  a  few  days  to  a 
week [21]. This technology allows a DNA fragment to be 
repeatedly sequenced in a very short time – a procedure 
that  is  known  as  deep  sequencing  and  delivers  greatly 
increased sensitivity and accuracy. These techniques have 
most  recently  been  extended  to  the  analysis  of  the 
transcriptome  by  what  is  known  as  RNA-Seq  [22-28]. 
Deep sequencing of RNA on Illumina’s Genome Analyzer 
and  HiSeq  instruments  as  well  as  Applied  Biosystems’ 
SOLiD instrument are now fast-developing alternatives 
for profiling the transcriptome.
Instead  of  using  molecular  hybridization  to  ‘capture’ 
transcript  molecules  of  interest,  RNA-Seq  samples 
transcripts  present  in  the  starting  material  by  direct 
sequencing. Transcript sequences are then mapped back 
to  a  reference  genome.  Reads  that  map  back  to  the 
reference  are  then  counted  to  assess  the  level  of  gene 
expression,  the  number  of  mapped  reads  being  the 
measure  of  expression  level  for  that  gene  or  genomic 
region.
There are several things that sequencing RNA can do 
that  microarrays  cannot.  Because  RNA-Seq  provides 
direct access to the sequence, junctions between exons 
can  be  assayed  without  prior  knowledge  of  the  gene 
structure,  RNA  editing  events  can  be  detected,  and 
knowledge  of  polymorphisms  can  provide  direct 
measurements  of  allele-specific  expression.  Because 
microarray probes are designed on the basis of inferences 
from prior genomic sequence data, and light intensity is 
used  as  surrogate  of  gene  expression,  microarrays  will 
miss exon junctions for novel expressed regions and RNA 
editing  events,  and  cannot  easily  detect  allele-specific 
differences in gene expression. Finally, because RNA-Seq 
provides direct access to the sequence this technique can 
be used on species for which a full genome sequence is 
not  available,  whereas  the  only  option  in  this  case  for 
microarrays is to hybridize RNA to a microarray designed 
for  another  species,  which  has  limitations  because  of 
sequence divergence.
There are also several general problems with measuring 
gene  expression  levels  genome-wide  that  sequencing 
RNA might make easier. Expressed regions of the genome 
that correspond to genes not currently identified might 
be  easier  to  detect  with  sequencing  than  with 
microarrays, because detection depends only on where 
reads map in the genome and not on whether that region 
is annotated. That limitation of microarrays can, however, 
be overcome by what are known as tiling arrays, in which 
overlapping probes are designed to assay sequences over 
the entire genome [29-32]. Tiling arrays were the basis 
for  the  discovery  of  genomic  ‘dark  matter’  –  extensive 
transcription  from  non-coding  regions  of  the  genome. 
However it is difficult using tiling arrays to balance the 
design of probes to achieve full genome coverage while 
avoiding as far as possible cross-hybridization potential, 
and this has led to controversy about the extent of the 
non-coding  transcriptome.  RNA-Seq  does  not  depend 
upon  hybridization and  thus  does  not  suffer  from  this 
potential artifact.
Another strength of RNA-Seq is in the quantification of 
individual  transcript  isoforms  [33,34].  Alternative 
splicing,  the  mechanism  whereby  different  isoforms  of 
proteins  are  generated,  is  acknowledged  to  be  an 
important  source  of  functional  diversity  in  eukaryotes, 
but it has been relatively little studied at the level of the 
transcriptome,  principally  because  of  the  difficulty  of 
measuring expression for each isoform. Splicing arrays 
exist  but  they  require  probes  designed  to  be 
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generated  only  if  the  genes  and  the  distinct  isoforms 
produced from them are already known [35]. Sequencing 
by  contrast  provides  direct  access  to  reads  that  span 
exon/exon boundaries and in theory makes it possible to 
study the expression of different isoforms for a gene and 
to make comparisons of isoform diversity and abundance. 
Additionally, sequencing appears to be better at detecting 
exon/exon junctions than arrays [29].
Practical advantages and drawbacks of microarrays 
and RNA sequencing
So  far,  we  have  discussed  the  advantages  and 
disadvantages of sequencing and arrays that are inherent 
in the two techniques. But there are also major practical 
considerations. The greatest current advantage of arrays 
is their relatively low cost compared with sequencing (in 
our lab about 10X). Presently, using a 12-plex array from 
Nimblegen our array costs are less than $100 per sample 
whereas sequencing is around $1,000 per sample. These 
costs  will  decrease  as  sequencing  output  increases. 
Another advantage is knowledge of biases in array data 
and mature analysis strategies and experimental designs 
for dealing with them. By comparison, sources of bias in 
sequence  data  are  still  being  actively  researched,  and 
optimum analytical strategies developed [36]. Meanwhile 
RNA-Seq continues to evolve, so it will take some time to 
develop appropriate standards for this tool.
One of the most important concerns about sequencing 
RNA is the depth of sequencing required to effectively 
sample  the  transcriptome.  This  equates  to  how  many 
times to sequence a sample. For highly expressed genes, 
small amounts of sequencing are sufficient, but for the 
middle and low end of expression levels, it is clear that 
many reads are needed. In the fly modENCODE samples 
for  example,  even  after  50  million  mapped  reads  new 
transcript discovery did not saturate [37]. In our hands, 
we  estimate  that  6-8  million  mapped  reads  provide 
adequate coverage to accurately estimate roughly 80-90% 
of  the  head  transcriptome  in  flies.  Other  tissues  are 
different and this is particularly the case for genes with 
low  levels  of  expression.  The  gene  doublesex,  a 
transcription  factor  involved  in  sexual  dimorphism  in 
flies, is not detected by RNA-Seq in the deeply sequenced 
modENCODE embryo samples [37] where it is known to 
be expressed in a few cells. This gene and others at similar 
expression  levels  missed  by  sequencing  highlight  the 
problem  of  detecting  genes  with  low  expression  no 
matter what the technique, be it arrays or sequencing. 
This example aside, failure to obtain sufficient coverage 
and  check  the  representation  of  this  coverage  (that  is, 
library  complexity)  will  provide  erroneous  metrics  of 
gene  expression  and  lead  to  false  inferences  even  for 
genes  that  are  detected.  Given  the  current  expense  of 
RNA-Seq,  and  the  excitement  about  the  prospects  of 
deep sequencing, this may cause some groups to avoid 
determining the coverage (that is, the number of reads) 
necessary  to  accurately  sample  the  transcriptome  of 
interest. High costs may also tempt some to avoid using 
biological replicates. These choices can lead to inaccurate 
estimates  of  gene  expression  level  and  thus  false 
inferences [36]. Another source of bias in sequencing is 
the heterogeneity of reads across an expressed region – 
that is, uneven sequencing depth along the length of a 
transcript. This heterogeneity in coverage will influence 
expression  estimates  for  transcripts  and  needs  to  be 
corrected [38,39,40]. Coverage and heterogeneity are not 
an  issue  in  microarrays  because  of  the  fixed  nature  of 
probes that capture the transcripts by hybridization.
A final consideration about arrays and sequencing is 
the  quantity  and  size  of  the  data.  In  expression 
microarrays the raw data are composed of image files, 
typically TIFF files that may be around 30 MB per array. 
These  TIFF  files  are  transformed  into  text  files  that 
contain  fluorescence  intensities  for  each  gene.  The 
Illumina instrument generates upwards of 600 GB of data 
files  but  the  sequence  files  (around  20-30  GB)  are 
typically  used  as  a  starting  point  for  analysis.  These 
sequence  files  are  an  order  of  magnitude  larger  than 
those from arrays and because of these large file sizes, 
Python, Perl, Unix command line, and other scripting are 
necessary to sort and experiment with these files. Using 
spreadsheet software will not be an option and therefore 
bioinformatics  support  is  necessary.  For  biologists 
unfamiliar with computer languages, there are growing 
alternatives  for  working  with  sequencing  data.  For 
example, many of the tools for sequencing data analysis 
are now available in Galaxy software, a web interface that 
provides a user friendly graphical interface [41,42].
An example from the fruit fly
As a way to introduce and discuss microarrays and deep 
sequencing for measuring the transcriptome we will use 
a  fly  example  from  our  own  laboratory:  specifically, 
experiments  designed  to  profile  gene  expression  in 
female and male heads of Drosophila pseudoobscura. This 
is one of several species of fly that we are profiling to 
validate evolutionarily novel D. melanogaster transcripts 
in the model organism Encyclopedia of DNA Elements 
(modENCODE) project [43]. We performed microarray 
and RNA-Seq experiments on the same samples and then 
compared  expression  measurements  between  micro-
arrays and RNA-Seq.
Figure 1 describes an expression experiment designed 
to  identify  genes  that  are  differentially  expressed  in 
D.  pseudoobscura  female  and  male  heads,  which  were 
manually dissected from flies over dry ice, after which 
total RNA was extracted followed by a poly A+ selection. 
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Page 3 of 9Figure 1. Data production workflow for microarrays. Microarrays require labeling of target material, hybridization to arrays, washing, and scanning 
to obtain measures of gene expression. RNA converted to cDNA from the sample will hybridize to the corresponding oligonucleotide targets, so 
that more highly expressed genes will be reflected in more abundant material hybridized and thus greater fluorescence intensity. In modern arrays, 
multiple probes are designed for a single gene in order to obtain fluorescence intensities that can be used as an index of gene expression.
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Page 4 of 9poly A+ selected mRNA was converted to cDNA using 
end-labeled random nonamers and reverse transcription. 
During this reaction, a fluorophore is added to the 5′ end 
of each short cDNA. In this case, the cDNA of one sex 
was labeled with one type of fluorescent dye (cyanine 3 or 
Cy3) and the cDNA of the other sex was labeled with a 
different  fluorescent  dye  (cyanine  5  or  Cy5)  with 
fluorescence  at  a  different  wavelength.  We  generated 
replicate samples (N = 4) and samples with dyes swapped 
between  females  and  males  in  order  to  control  for 
technical artifacts due to labeling and dye biases and to 
measure  the  inherent  variability  in  gene  expression 
irrespective of the sex of the sample.
As  with  any  assay,  replicate  samples  are  critical  for 
statistical analysis. The female and male labeled cDNA 
samples were mixed and applied to the microarray for 
hybridization. cDNAs that are complementary to probes 
on the microarray hybridize on the basis of simple first 
principles: more highly expressed genes will have more 
transcripts converted to labeled cDNA, and these more 
abundant cDNAs will bind more to their target probes 
than  those  of  less  expressed  genes.  Because  we  co-
hybridized  samples  labeled  with  different  fluorescent 
dyes we can take a ratiometric expression score between 
female and male heads: that is, genes that are more highly 
expressed  in  one  sex  than  in  the  other  will  hybridize 
more to the target probe and generate a stronger signal. 
Genes that are expressed at the same level in both sexes 
will  have  equivalent  amounts  of  transcript  bound  to 
probes and so the signal will be a combination of both 
Cy3  and  Cy5  signal  thereby  generating  a  signal 
intermediate between the two (yellow fluorescence). The 
analysis and normalization methods for microarrays are 
highly developed [12] and thus this experiment should 
allow  the  differences  in  steady-state  mRNA  levels 
between  female  and  male  head  tissue  to  be  reliably 
measured.
Figure 2 shows the same analysis performed by RNA-
Seq,  using  an  Illumina  Genome  Analyzer  and  a 
commonly deployed protocol for preparing libraries [44]. 
First,  the  transcriptomes  for  females  and  males  are 
fragmented  by  alkaline  hydrolysis,  then  reverse-
transcribed  to  make  double-stranded  cDNAs  using 
random hexamer primers. Next, the ends of transcript 
fragments  are  prepared  to  enable  oligonucleotide 
adaptors to be ligated onto the ends. Fragments are then 
size-selected, amplified by PCR and injected into a flow 
cell. The flow cell is a glass slide that contains a lawn of 
oligonucleotides complementary to the adaptors ligated 
to transcripts and with a series of separate lanes in which 
sequencing reactions take place.
Once  the  adaptors  on  the  DNA  fragments  have 
hybridized to the complementary oligonucleotides in the 
flow  cell,  the  fragments  are  amplified  by  isothermal 
bridge amplification to generate clusters of DNA clones. 
(In isothermal bridge amplification, the templates arch 
over and bind to adjacent oligonucleotides and then DNA 
polymerase  copies  the  templates.)  Double-stranded 
DNAs  are  denatured  and  the  process  is  repeated  to 
generate clusters of DNA clones. Next, the free 3′ OH 
ends  of  the  linearized  clusters  are  blocked  to  prevent 
nonspecific sequencing reactions. Finally, the clusters are 
denatured and a sequencing primer is hybridized to the 
linearized and blocked clusters.
Sequencing reactions consist of a series of reactions to 
image  individual  bases  within  each  cluster.  Bases  are 
imaged  by  using  reversible  fluorophore  terminator 
nucleotides. The first base in the cluster is identified by 
adding four labeled reversible terminators, primers, and 
polymerase. A laser is used to excite the fluorophores and 
this allows identification of the first base. The next cycle 
repeats the incorporation of four reversible terminator 
nucleotides,  primers,  and  polymerase.  A  laser  again 
excites  the  terminators  and  bases  are  identified.  These 
cycles  of  adding  reagents,  followed  by  laser  excitation, 
and  data  capture  are  repeated  to  produce  a  read  and 
typical reads range from 25 to over 75 base pairs in size. 
At the end of a run (3-7 days or more depending on read 
length)  there  are  30-40  million  (possibly  more)  high 
quality sequences.
The RNA-Seq measure of gene expression is density of 
reads mapping to a particular transcript. For species with 
sequenced genomes, a common method is to map reads 
to a reference genome. Illumina provides a mapper called 
ELAND but many free open source tools are available. 
The tools that we have used most extensively for RNA-
Seq are the Tuxedo Suite Tools (Bowtie [45], a short read 
mapper;  Tophat  [46],  a  splice  junction  identifier,  and 
Cufflinks  [33],  a  transcript  assembler).  Two  expression 
metrics  are  commonly  used  which  provide  a  value 
normalized  by  overall  sequencing  depth,  FPKM 
(expected fragments per kilobase of transcript per million 
fragments mapped) and RPKM (reads per kilobase per 
million mapped reads) [23,33,40], which are conceptually 
similar.  In  the  example  given  in  Figure  2,  we  estimate 
expression in units of RPKM by quantifying reads that 
map  with  genes  predicted  from  genomic  sequence. 
Therefore, higher RPKM in females would be examples of 
genes with female-biased expression, higher RPKM for 
males would be genes with male-biased expression, and 
equivalent  RPKM  in  both  sexes  would  be  examples  of 
non-sex-biased genes.
Do arrays and RNA-Seq tell a consistent story?
A key first question is whether, when used to ask exactly 
the same question, both techniques give the same answer. 
Comparing expression metrics from array intensities to 
RNA-Seq density shows a strong congruence (Figure 3). 
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Page 5 of 9Figure 2. Data production workflow for RNA-Seq. RNA-Seq requires building libraries of fragmented RNA that are then converted to cDNA by 
reverse transcription, followed by adaptor ligation and size selection. Sequencing libraries are prepared for clustering on an 8 lane flow cell and 
sequencing-by-synthesis is used to generate tens of millions of sequences per sample that can be mapped to a reference genome. The number of 
reads that map to a scaled region of genome space are the index of the expression level of the gene.
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Page 6 of 9The relationship is not quite linear, as there appears to be 
a slight compression in the array data at the high end, but 
the  vast  majority  of  the  expression  values  are  similar 
between the methods. Scatter increases at low expression, 
which  is  not  surprising,  as  background  correction 
methods  for  arrays  are  complicated  when  signal  levels 
approach noise levels. Similarly, RNA-Seq is a sampling 
method and stochastic events become a source of error 
in  the  quantification  of  rare  transcripts  [47].  There  is, 
however, one consistent difference in our comparisons in 
Drosophila. There is a large range of expression values at 
the low end on arrays that that are undetectable by RNA-
Seq. We cannot explain this difference, but whatever the 
cause, it does not affect the measurement of differential 
expression  at  expression  levels  that  are  detectable  by 
RNA-Seq  (Figure  3).  In  our  experiment,  we  used 
biological  replicate  samples  for  the  arrays  and  applied 
moderated  t-tests  to  detect  those  genes  that  were 
differentially  expressed  between  females  and  males.  In 
the  analysis  in  Figure  3,  our  goal  was  to  compare 
expression  measurements  between  the  platforms.  The 
genes showing sex-biased expression (red and blue dots 
in  Figure  3)  are  in  outstanding  agreement  between 
microarrays  and  RNA-Seq.  We  have  observed  similar 
congruence  in  the  extremely  deep  RNA-Seq  data  in 
modENCODE D. melanogaster female and male samples 
[37]. Annotated sex-biased genes based on the extensive 
array-based  literature  [48]  and  the  deeply  sequenced 
modENCODE samples report the same biology.
The answer is yes
Both  sequencing  and  hybridizing  mRNA  to  arrays  are 
high-throughput ways to profile the transcriptome and 
for problems that can be addressed by both, they show 
similar  performance  and  complement  each  other 
[29,47,49].  Detecting  genes  with  low  expression  will 
Figure 3. Comparison of array and RNA-Seq data for measuring differential gene expression in the heads of male and female 
D. pseudoobscura. (a) Results for female heads; (b) results for male heads. We used custom designed Nimblegen arrays to an early release of the 
D. pseudoobscura annotation. This array consists of 50-mer probes selected without bias to gene position, and with an average of 10 probes per 
gene model. A full description of this array platform can be found in the GEO under platform number GPL4631. Robust Multi-array Averaging (RMA) 
[50] was used to normalize array experiments and normalization improves the correlation between arrays and sequencing results. A full description 
of the analysis and all sequencing data can be found in [51]. Colored circles are genes identified as differentially expressed between females 
and males by microarray analysis with four biological replicates. In this case, one of the four biological replicates was prepared for sequencing 
by fragmenting RNA using alkaline hydrolysis and constructing a cDNA library for sequencing. For these analyses, we generated about 6 million 
36 base pair reads from the Illumina GA I platform and the number of reads per kilobase per million mapped reads (RPKM) was calculated by 
counting the number of unique mapping reads from the default Illumina mapper (ELAND but the same pattern holds for Bowtie) to the same 
coding sequence models that were used for constructing probes for the microarray. The correlation between fluorescence intensity as a surrogate 
for gene expression and the RPKM metric as obtained by mRNA-Seq is high (Pearson’s r = 0.90-0.91; Spearman’s rho = 0.90-0.91) and slightly higher 
for just the genes identified as differentially expressed by microarrays (Pearson’s r = 0.89-0.92; Spearman’s rho = 0.90-0.94). In the case of fold change 
(c) measurements (female/male), the congruence is reasonable for the entire data set (Pearson’s r = 0.62; Spearman’s rho = 0.54) but high in the case 
of the fold change measurements for the genes with sex-biased expression (Pearson’s r = 0.92; Spearman’s rho = 0.89).
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Page 7 of 9remain  a  problem  for  both  techniques,  but  there  are 
some  applications,  such  as  transcript  discovery  and 
isoform identification, where RNA-Seq will be the better 
choice. Given the substantial agreement between the two 
methods,  the  array  data  in  the  literature  should  be 
durable.
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